Skip to Main Content

Paper Details

SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy.
Cancer Cell
47
2020
Chromatin, G9a, HDAC3, MEK1/2, MEKi, PDAC, Pancreatic Cancer, SETD5, SETD5 complex, histone methyltransferase, mouse, pancreatic ductal adenocarcinoma, patient, tumor
Author NameAffiliation
Natasha M FloresThe University of Texas MD Anderson Cancer Center
Natasha M FloresThe University of Texas MD Anderson Cancer Center
Joshua E Elias
Anirban MaitraThe University of Texas MD Anderson Cancer Center
Michael C BassikStanford University School of Medicine
Michael C BassikStanford University School of Medicine
Michael-Christopher KeoghEpiCypher Inc.
Julien SageStanford University School of Medicine
Or GozaniStanford University
  • 1 - 9

Datasets

Release 1.2